Details
Stereochemistry | UNKNOWN |
Molecular Formula | 3C4H3O4S.6Li.Sb |
Molecular Weight | 604.794 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Sb+3].[O-]C(=O)CC([S-])C([O-])=O.[O-]C(=O)CC([S-])C([O-])=O.[O-]C(=O)CC([S-])C([O-])=O
InChI
InChIKey=YECBTZNXNRHKJD-UHFFFAOYSA-E
InChI=1S/3C4H6O4S.6Li.Sb/c3*5-3(6)1-2(9)4(7)8;;;;;;;/h3*2,9H,1H2,(H,5,6)(H,7,8);;;;;;;/q;;;6*+1;+3/p-9
DescriptionSources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Sources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332
Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Stibophen (Fuadin), an organic trivalent antimony compound, has been used for many years in the treatment of schistosomiasis. Stibophen is used as treatment of schistosomiasis by intramuscular injection. Stibophen is known to act by selectively inhibiting worm PFK.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Laboratory studies on the joint effects of certain tris (p-aminophenyl) carbonium salts and antimonials as antischistosomal drugs. | 1965 |
|
Current chemotherapy of schistosomiasis japonica in the Philippines. | 1976 Jun |
|
[Substantiation of maximum permissible levels of antimony trioxide and pentasulide in the atmospheric air of inhabitated places]. | 1989 Apr |
|
Antimony impairs nucleotide excision repair: XPA and XPE as potential molecular targets. | 2010 Jul 19 |
|
Investigation on the pharmacological profile of 2,6-diacetylpyridine bis(benzoylhydrazone) derivatives and their antimony(III) and bismuth(III) complexes. | 2012 Jul |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000086952
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
PRIMARY | |||
|
206-173-0
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
PRIMARY | |||
|
C79917
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
PRIMARY | |||
|
DTXSID40952817
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
PRIMARY | |||
|
m566
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
PRIMARY | Merck Index | ||
|
72062
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
PRIMARY | |||
|
SUB05528MIG
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
PRIMARY | |||
|
4122
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
PRIMARY | |||
|
TX973XBY8N
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
PRIMARY | |||
|
305-97-5
Created by
admin on Fri Dec 15 17:19:52 GMT 2023 , Edited by admin on Fri Dec 15 17:19:52 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD